Granulomatosis with Polyangiitis: Role of Nephrologist in Management of a Rare Systemic Disease

Introduction: Granulomatosis with polyangiitis (GPA) is a rare form of systemic vasculitis primarily affecting the upper respiratory tract, lungs, and kidneys and associated with antineutrophil cytoplasmic antibodies (ANCA). This case highlights the importance of the nephrologist in the interdisciplinary management of GPA with a multisystemic presentation. Case Description: A 39-year-old African American female presented with a saddle nose deformity and chest pain. A computed tomography (CT) scan revealed mediastinal lymphadenopathy, numerous lung masses, and total obstruction of the nares. A nasal biopsy showed pyogenic granuloma. Serum creatinine (SCr) was 0.59 mg/dl. Anti-proteinase 3 titers were positive (1:160). Urine studies showed microhematuria and low-grade proteinuria with a urine protein:creatinine ratio (UPC) of 0.85. A kidney biopsy showed pauci-immune focal necrotizing glomerulonephritis, consistent with ANCA-associated vasculitis. Corticosteroids and rituximab were initiated by nephrology. A month later, SCr increased to 2.86 mg/dl. She developed severe headaches, periorbital edema, and vision changes, leading to the diagnosis of dacryocystitis. A lacrimal gland biopsy showed marked acute inflammation due to histiocytosis, plasma cells, and lymphocytes. Pulse steroids and rituximab were re-administered, followed by steroid tapering per the PEXIVAS protocol and the addition of avacopan. Though renal function improved, she had worsening orbital symptoms. She received another cycle of pulse-dose steroids and two doses of cyclophosphamide, with improvement in eye and nasal symptoms. At her most recent visit, SCr was 0.86 mg/dl and UPC was 0.45. Continued immunosuppression with rituximab for 18–24 months, along with avacopan, was planned. Discussion: A multidisciplinary team including nephrology, rheumatology, pulmonology, and ophthalmology managed the patient. The nephrologist played a crucial role in diagnosing the disease with a renal biopsy (performed when normal renal function and only mild abnormalities in urine were present) and initiating immunosuppression. Successful management of this complex case exemplifies the invaluable contribution of the nephrologist as part of the interdisciplinary team navigating the challenges posed by systemic GPA.

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2024-10-01
DOI
https://doi.org/10.1681/asn.2024g623hhjz
Primary Topic
Vasculitis and related conditions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Granulomatosis with Polyangiitis: Role of Nephrologist in Management of a Rare Systemic Disease

Oves Siddiqui, Dhirisha Bhatt, Margaret Hastings, Usha Kumari
Journal of the American Society of Nephrology
Vasculitis and related conditions
article

Granulomatosis with Polyangiitis: Role of Nephrologist in Management of a Rare Systemic Disease

Oves Siddiqui, Dhirisha Bhatt, Margaret Hastings, Usha Kumari
article en

Abstract

Introduction: Granulomatosis with polyangiitis (GPA) is a rare form of systemic vasculitis primarily affecting the upper respiratory tract, lungs, and kidneys and associated with antineutrophil cytoplasmic antibodies (ANCA). This case highlights the importance of the nephrologist in the interdisciplinary management of GPA with a multisystemic presentation. Case Description: A 39-year-old African American female presented with a saddle nose deformity and chest pain. A computed tomography (CT) scan revealed mediastinal lymphadenopathy, numerous lung masses, and total obstruction of the nares. A nasal biopsy showed pyogenic granuloma. Serum creatinine (SCr) was 0.59 mg/dl. Anti-proteinase 3 titers were positive (1:160). Urine studies showed microhematuria and low-grade proteinuria with a urine protein:creatinine ratio (UPC) of 0.85. A kidney biopsy showed pauci-immune focal necrotizing glomerulonephritis, consistent with ANCA-associated vasculitis. Corticosteroids and rituximab were initiated by nephrology. A month later, SCr increased to 2.86 mg/dl. She developed severe headaches, periorbital edema, and vision changes, leading to the diagnosis of dacryocystitis. A lacrimal gland biopsy showed marked acute inflammation due to histiocytosis, plasma cells, and lymphocytes. Pulse steroids and rituximab were re-administered, followed by steroid tapering per the PEXIVAS protocol and the addition of avacopan. Though renal function improved, she had worsening orbital symptoms. She received another cycle of pulse-dose steroids and two doses of cyclophosphamide, with improvement in eye and nasal symptoms. At her most recent visit, SCr was 0.86 mg/dl and UPC was 0.45. Continued immunosuppression with rituximab for 18–24 months, along with avacopan, was planned. Discussion: A multidisciplinary team including nephrology, rheumatology, pulmonology, and ophthalmology managed the patient. The nephrologist played a crucial role in diagnosing the disease with a renal biopsy (performed when normal renal function and only mild abnormalities in urine were present) and initiating immunosuppression. Successful management of this complex case exemplifies the invaluable contribution of the nephrologist as part of the interdisciplinary team navigating the challenges posed by systemic GPA.

Journal of the American Society of NephrologyVol. 35(10S)
University of Tennessee Health Science Center (US)
Good health and well-being
Openalex Percentile: Top 65%
Vasculitis and related conditions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.